Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Pilot study on the bioactivity of vitamin d in the skin after oral supplementation.

Curiel-Lewandrowski C, Tang JY, Einspahr JG, Bermudez Y, Hsu CH, Rezaee M, Lee AH, Tangrea J, Parnes HL, Alberts DS, Chow HH.

Cancer Prev Res (Phila). 2015 Jun;8(6):563-9. doi: 10.1158/1940-6207.CAPR-14-0280. Epub 2015 Apr 2.

2.

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Kolesar JM, Pomplun M, Havighurst T, Stublaski J, Wollmer B, Kim K, Tangrea JA, Parnes HL, House MG, Gee J, Messing E, Bailey HH.

J Oncol Pharm Pract. 2015 Apr;21(2):128-31. doi: 10.1177/1078155214528552. Epub 2014 Mar 17.

3.

A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.

Linden KG, Leachman SA, Zager JS, Jakowatz JG, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL Jr.

Cancer Prev Res (Phila). 2014 May;7(5):496-504. doi: 10.1158/1940-6207.CAPR-13-0189. Epub 2014 Mar 10.

4.

Prostate cancer prevention: agent development strategies.

Parnes HL, House MG, Tangrea JA.

Recent Results Cancer Res. 2014;202:121-31. doi: 10.1007/978-3-642-45195-9_15.

PMID:
24531786
5.

Prostate cancer prevention: strategies for agent development.

Parnes HL, House MG, Tangrea JA.

Curr Opin Oncol. 2013 May;25(3):242-51. doi: 10.1097/CCO.0b013e32835fc8d4. Review.

PMID:
23518594
6.

Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.

Curiel-Lewandrowski C, Swetter SM, Einspahr JG, Hsu CH, Nagle R, Sagerman P, Tangrea J, Parnes H, Alberts DS, Chow HH.

Cancer. 2012 Dec 1;118(23):5848-56. doi: 10.1002/cncr.27540. Epub 2012 May 17.

7.

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, Kolesar J, Harris L, Faerber A, Havighurst T, Young JM, Efros M, Getzenberg RH, Wheeler MA, Tangrea J, Parnes H, House M, Busby JE, Hohl R, Bailey H.

Cancer Prev Res (Phila). 2012 Apr;5(4):621-30. doi: 10.1158/1940-6207.CAPR-11-0455. Epub 2012 Jan 31.

8.

Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.

Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH.

Cancer Prev Res (Phila). 2012 Feb;5(2):290-8. doi: 10.1158/1940-6207.CAPR-11-0306. Epub 2011 Nov 1.

9.

Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland.

Kidd LR, Hein DW, Woodson K, Taylor PR, Albanes D, Virtamo J, Tangrea JA.

Biochem Genet. 2011 Feb;49(1-2):73-82. doi: 10.1007/s10528-010-9386-4. Epub 2010 Oct 8.

10.

Epidemiological and clinical studies of nutrition.

Gibson TM, Ferrucci LM, Tangrea JA, Schatzkin A.

Semin Oncol. 2010 Jun;37(3):282-96. doi: 10.1053/j.seminoncol.2010.05.011. Review.

11.

Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland.

Brock KE, Graubard BI, Fraser DR, Weinstein SJ, Stolzenberg-Solomon RZ, Lim U, Tangrea JA, Virtamo J, Ke L, Snyder K, Albanes D.

Eur J Clin Nutr. 2010 Mar;64(3):280-8. doi: 10.1038/ejcn.2009.137. Epub 2010 Jan 6.

12.

Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.

Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2784-6. No abstract available.

13.

The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.

Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.

J Urol. 2008 Feb;179(2):508-11; discussion 511-2.

PMID:
18076912
14.

Association of IL-10 polymorphisms with prostate cancer risk and grade of disease.

Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Causes Control. 2008 Mar;19(2):119-24. Epub 2007 Nov 13.

PMID:
17999153
15.

CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease.

Woodson K, O'Reilly KJ, Ward DE, Walter J, Hanson J, Walk EL, Tangrea JA.

Epigenetics. 2006 Oct-Dec;1(4):183-6. Epub 2006 Oct 24.

PMID:
17998819
16.

Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.

Yang HP, Woodson K, Taylor PR, Pietinen P, Albanes D, Virtamo J, Tangrea JA.

Eur J Cancer Prev. 2006 Jun;15(3):249-53.

PMID:
16679868
17.

Gene promoter methylation in prostate tumor-associated stromal cells.

Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.

J Natl Cancer Inst. 2006 Feb 15;98(4):255-61.

PMID:
16478744
18.

Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Diaw L, Roth M, Schwinn DA, d'Alelio ME, Green LJ, Tangrea JA.

In Vitro Cell Dev Biol Anim. 2005 May-Jun;41(5-6):142-8.

PMID:
16153146
19.

Common leptin receptor polymorphisms do not modify the effect of alcohol ingestion on serum leptin levels in a controlled feeding and alcohol ingestion study.

Roth MJ, Paltoo DN, Albert PS, Baer DJ, Judd JT, Tangrea J, Taylor PR.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1576-8.

20.

Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial.

Woodson K, Weisenberger DJ, Campan M, Laird PW, Tangrea J, Johnson LL, Schatzkin A, Lanza E.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1219-23.

21.

Aspirin use and mortality from cancer in a prospective cohort study.

Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E.

Anticancer Res. 2004 Sep-Oct;24(5B):3177-84.

22.

Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.

Dorgan JF, Boakye NA, Fears TR, Schleicher RL, Helsel W, Anderson C, Robinson J, Guin JD, Lessin S, Ratnasinghe LD, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1276-82.

23.

Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.

Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA.

Prostate. 2004 Jun 15;60(1):25-31.

PMID:
15129426
24.

A survey of gene-specific methylation in human prostate cancer among black and white men.

Woodson K, Hanson J, Tangrea J.

Cancer Lett. 2004 Mar 18;205(2):181-8.

PMID:
15036650
25.

Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women.

Woodson K, Flood A, Green L, Tangrea JA, Hanson J, Cash B, Schatzkin A, Schoenfeld P.

J Natl Cancer Inst. 2004 Mar 3;96(5):407-10.

PMID:
14996863
26.

Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).

Woodson K, Tangrea JA, Lehman TA, Modali R, Taylor KM, Snyder K, Taylor PR, Virtamo J, Albanes D.

Cancer Causes Control. 2003 Aug;14(6):513-8.

PMID:
12948282
27.

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).

Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group.

Cancer Causes Control. 2003 Jun;14(5):403-11.

PMID:
12946034
28.
29.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

30.

Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites.

Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J.

Prostate. 2003 May 15;55(3):199-205.

PMID:
12692786
31.

Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland.

Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D.

Cancer Lett. 2003 Mar 10;191(2):171-8.

PMID:
12618330
32.
33.

Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States).

Colbert LH, Lanza E, Ballard-Barbash R, Slattery ML, Tangrea JA, Caan B, Paskett ED, Iber F, Kikendall W, Lance P, Shike M, Schoen RE, Daston C, Schatzkin A; Polyp Prevention Trial Study Group.

Cancer Causes Control. 2002 Jun;13(5):445-53.

PMID:
12146849
34.

Physical activity and lung cancer risk in male smokers.

Colbert LH, Hartman TJ, Tangrea JA, Pietinen P, Virtamo J, Taylor PR, Albanes D.

Int J Cancer. 2002 Apr 10;98(5):770-3.

35.

Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V.

Am J Epidemiol. 2001 Dec 15;154(12):1119-25.

PMID:
11744517
36.

Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial.

Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A.

J Natl Cancer Inst. 2001 Dec 5;93(23):1799-805.

PMID:
11734596
37.

Limitations of the case-only design for identifying gene-environment interactions.

Albert PS, Ratnasinghe D, Tangrea J, Wacholder S.

Am J Epidemiol. 2001 Oct 15;154(8):687-93.

PMID:
11590080
38.

Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?

Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC, Tangrea JA.

Anticancer Res. 2001 May-Jun;21(3C):2141-7.

PMID:
11501838
39.

Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association.

Ratnasinghe D, Tangrea JA, Stewart C, Bhat NK, Virtamo J, Albanes D, Taylor PR.

Anticancer Res. 2001 Mar-Apr;21(2B):1295-9.

PMID:
11396202
40.

Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk.

Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, Barrett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):119-23.

41.

Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer.

Woodson K, Mason J, Choi SW, Hartman T, Tangrea J, Virtamo J, Taylor PR, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):69-74.

42.

Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland.

Misra RR, Tangrea JA, Virtamo J, Ratnasinghe D, Andersen MR, Barrett M, Taylor PR, Albanes D.

Cancer Lett. 2001 Mar 26;164(2):161-7.

PMID:
11179831
43.

Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.

Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D.

Prostate. 2001 Jan 1;46(1):33-8.

PMID:
11170129
44.

Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk.

Ratnasinghe D, Tangrea JA, Andersen MR, Barrett MJ, Virtamo J, Taylor PR, Albanes D.

Cancer Res. 2000 Nov 15;60(22):6381-3.

45.

Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland).

Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J.

Cancer Causes Control. 2000 Oct;11(9):859-67.

PMID:
11075876
46.

Serum carotenoids are associated with increased lung cancer risk among alcohol drinkers, but not among non-drinkers in a cohort of tin miners.

Ratnasinghe D, Forman MR, Tangrea JA, Qiao Y, Yao SX, Gunter EW, Barrett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Alcohol Alcohol. 2000 Jul-Aug;35(4):355-60.

PMID:
10906000
47.

Association between GSTM1*0 and squamous dysplasia of the esophagus in the high risk region of Linxian, China.

Roth MJ, Dawsey SM, Wang G, Tangrea JA, Zhou B, Ratnasinghe D, Woodson KG, Olivero OA, Poirier MC, Frye BL, Taylor PR, Weston A.

Cancer Lett. 2000 Aug 1;156(1):73-81.

PMID:
10840162
48.

Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland)

Albanes D, Malila N, Taylor PR, Huttunen JK, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Barrett MJ, Pietinen P, Hartman TJ, Sipponen P, Lewin K, Teerenhovi L, Hietanen P, Tangrea JA, Virtanen M, Heinonen OP.

Cancer Causes Control. 2000 Mar;11(3):197-205.

PMID:
10782653
49.

Serum tocopherols, selenium and lung cancer risk among tin miners in China.

Ratnasinghe D, Tangrea JA, Forman MR, Hartman T, Gunter EW, Qiao YL, Yao SX, Barett MJ, Giffen CA, Erozan Y, Tockman MS, Taylor PR.

Cancer Causes Control. 2000 Feb;11(2):129-35.

PMID:
10710196
50.

Association between serum alpha-tocopherol and serum androgens and estrogens in older men.

Hartman TJ, Dorgan JF, Virtamo J, Tangrea JA, Taylor PR, Albanes D.

Nutr Cancer. 1999;35(1):10-5.

PMID:
10624701

Supplemental Content

Loading ...
Support Center